 |
인쇄하기
취소
|
Ildong's CP rated 'A3+'
Korea Ratings Corporation said on September 2 it has assigned a 'A3+' to Ildong Pharm's commercial paper.
KR said Ildong's solid sales performance of flagship items is considered the best competitiveness of the company.
Also, the rating reflects the expectation on increases of new drugs and better portfolio in the cardiovascular sector.
Allowing for the company's average cash-generati...
KR said Ildong's solid sales performance of flagship items is considered the best competitiveness of the company.
Also, the rating reflects the expectation on increases of new drugs and better portfolio in the cardiovascular sector.
Allowing for the company's average cash-generati...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.